|
|
|
Volumn 7, Issue 5 SUPPL., 2001, Pages
|
|
A new statin: A new standard
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ATORVASTATIN;
CREATINE KINASE;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
PLACEBO;
ROSUVASTATIN;
STATIN;
TRIACYLGLYCEROL LIPASE;
UNCLASSIFIED DRUG;
ADULT;
AGED;
CHOLESTEROL BLOOD LEVEL;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CREATINE KINASE BLOOD LEVEL;
DOSE RESPONSE;
DRUG EFFECT;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
GASTROINTESTINAL SYMPTOM;
HEADACHE;
HUMAN;
HYPERCHOLESTEROLEMIA;
MAJOR CLINICAL STUDY;
MALE;
MONOTHERAPY;
MULTICENTER STUDY;
PHASE 2 CLINICAL TRIAL;
POSTMENOPAUSE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
TRIACYLGLYCEROL LIPASE BLOOD LEVEL;
UPPER RESPIRATORY TRACT INFECTION;
ADOLESCENT;
ADULT;
AGED;
ANTICHOLESTEREMIC AGENTS;
CORONARY ARTERIOSCLEROSIS;
FEMALE;
FLUOROBENZENES;
HUMANS;
LIPOPROTEINS, LDL;
MALE;
MIDDLE AGED;
PYRIMIDINES;
SULFONAMIDES;
TREATMENT OUTCOME;
UNITED STATES;
|
|
EID: 0034997149
PISSN: 10880224
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (5)
|
|
References (10)
|
